Syndax Pharmaceuticals Inc - Has Sufficient Cash Runway to Fund Its Research, Clinical Development and Commercial Operations Through 2026
Syndax Pharmicals Inc-在2026年之前有足够的现金流为其研究、临床开发和商业运营提供资金
Syndax Pharmaceuticals Inc - Has Sufficient Cash Runway to Fund Its Research, Clinical Development and Commercial Operations Through 2026
Syndax Pharmicals Inc-在2026年之前有足够的现金流为其研究、临床开发和商业运营提供资金
使用浏览器的分享功能,分享给你的好友吧